Publication:
Predictors of progression in primary progressive multiple sclerosis in a large Turkish cohort

dc.contributor.coauthorDerle, Eda
dc.contributor.coauthorSayat-Gürel, Güliz
dc.contributor.coauthorKarabudak, Rana
dc.contributor.coauthorTuncer, Aslı
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorVural, Atay
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:03:26Z
dc.date.issued2020
dc.description.abstractBackground: Studies on the predictors of progression for primary progressive multiple sclerosis (PPMS) are limited and there is no information in the literature for populations outside Europe and North America. In this study, we aimed to identify predictors of progression in a large Turkish PPMS cohort. Methods: We analyzed a cohort of 157 PPMS patients to investigate the effect of age of onset, gender, onset symptoms, presence or absence of relapses, and baseline gadolinium-enhancing lesions on the rate of progression to EDSS6 by using Kaplan-Meier analysis and multivariate Cox regression. Results: Older age of onset and presence of spinal motor symptoms at onset were associated with a shorter time to EDSS6 and presence of supratentorial signs at onset was associated with a longer time to EDSS6 according to Kaplan-Meier analysis. These factors remained significant after multivariate Cox-regression analysis. Clinical relapses were present in 22.3% and gadolinium-enhancing lesions on baseline MRI were present in 28% of patients, but these factors were not predictive of time to EDSS6. Conclusion: We identified age of onset and symptom at onset as predictors of progression in Turkish PPMS patients. Presence of clinical relapses or baseline gadolinium-enhancing lesions did not affect PPMS progression rate.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume38
dc.identifier.doi10.1016/j.msard.2019.101520
dc.identifier.eissn2211-0356
dc.identifier.issn2211-0348
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85074926462
dc.identifier.urihttps://doi.org/10.1016/j.msard.2019.101520
dc.identifier.urihttps://hdl.handle.net/20.500.14288/8468
dc.identifier.wos521648000035
dc.keywordsPrimary progressive multiple sclerosis
dc.keywordsPrognostic factors
dc.keywordsDisease activity
dc.keywordsNatural history
dc.keywordsMagnetic resonance imaging
dc.language.isoeng
dc.publisherElsevier Sci Ltd
dc.relation.ispartofMultiple Sclerosis and Related Disorders
dc.subjectClinical neuropsychology
dc.titlePredictors of progression in primary progressive multiple sclerosis in a large Turkish cohort
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorVural, Atay
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files